Phase I Study Of Intravenous DOTAP:Cholesterol-Fus1 Liposome Complex (DOTAP:Chol-fus1) In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy.
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2012
At a glance
- Drugs CNVN 202 (Primary)
- Indications Non-small cell lung cancer; Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 26 Apr 2012 Full results published in PLoS One, as reported in a Genprex media release.
- 14 Jul 2011 Results were presented at the Annual Meeting of the American Association for Cancer Research (AACR).